References
- Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2016. Geneva, World Health Organization; 2018.
- Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917.
- Løkke A, Fabricius PG, Vestbo J, et al. Prevalence of chronic obstructive pulmonary disease in Copenhagen. Results from The Copenhagen City Heart Study. Ugeskr Laeger. 2007;169:3956–3960.
- Hansen JG, Pedersen L, Overvad K, et al. The prevalence of chronic obstructive pulmonary disease among danes aged 45-84 years: Population-based study. COPD J Chronic Obstr Pulm Dis. 2008;5:347–352.
- Mouronte-Roibás C, Leiro-Fernández V, Fernández-Villar A, et al. COPD, emphysema and the onset of lung cancer. A systematic review. Cancer Lett. 2016;382:240–244.
- Yang IA, Relan V, Wright CM, et al. Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. Expert Opin Ther Targets. 2011;15:439–456.
- Sekine Y, Behnia M, Fujisawa T. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. Lung Cancer. 2002;37:95–101.
- Loganathan RS, Stover DE, Shi W, et al. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest. 2006;129:1305–1312.
- Gottlieb M, Marsaa K, Godtfredsen NS, et al. Prevalence and management of pulmonary comorbidity in patients with lung and head and neck cancer. Acta Oncol. 2015;54:767–771.
- Zhai R, Yu X, Shafer A, et al. The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection. Chest. 2014;145:346–353.
- Sekine Y, Suzuki H, Yamada Y, et al. Severity of chronic obstructive pulmonary disease and its relationship to lung cancer prognosis after surgical resection. Thorac Cardiovasc Surg. 2013;61:124–130.
- Gullón JA, Suárez I, Medina A, et al. Role of emphysema and airway obstruction in prognosis of lung cancer. Lung Cancer. 2011;71:182–185.
- Tammemagi CM, Neslund-Dudas C, Simoff M, et al. Impact of comorbidity on lung cancer survival. Int J Cancer. 2003;103:792–802.
- Ahn DH, Mehta N, Yorio JT, et al. Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancer. Clin Lung Cancer. 2013;14:644–650.
- Iachina M, Jakobsen E, Møller H, et al. The Effect of Different Comorbidities on Survival of Non-small Cells Lung Cancer Patients. Lung. 2015;193:291–297.
- Prignot J. Quantification and chemical markers of tobacco-exposure. Eur J Respir Dis. 1987;70:1–7.
- López-Encuentra A, Astudillo J, Cerezal J, et al. Prognostic value of chronic obstructive pulmonary disease in 2994 cases of lung cancer. Eur J Cardio-Thoracic Surg. 2005;27:8–13.
- Kiri VA, Soriano JB, Visick G, et al. Recent trends in lung cancer and its association with COPD: an analysis using the UK GP research database. Prim Care Respir J. 2009;19:57–61.